Anti-glypican 3 antibodies
MYPI2025000960A0Undetermined Publication Date: 2023-04-15LEPU BIOPHARMA CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025000960
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-02-10
- Publication Date
- 2023-04-15
Abstract
This disclosure provides anti-GPC3 antibodies, including murine antibodies, humanized antibodies, and those with further optimized CDR sequences. The newly disclosed antibodies exhibited higher cell-based binding efficiency than the leading anti-GPC3 antibody candidate under clinical development.
Need to check novelty before this filing date? Find Prior Art
